Effectiveness of Trauma Treatment in the Specialist Health Care Services

Launched by VESTRE VIKEN HOSPITAL TRUST · Nov 13, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of two therapies for treating post-traumatic stress disorder (PTSD): Eye Movement Desensitization and Reprocessing (EMDR) and Cognitive Therapy for PTSD (CT-PTSD). The goal is to understand how well these therapies work in helping patients with PTSD and related symptoms, as well as how they improve overall quality of life and functioning. The study will involve 270 patients, who will be randomly assigned to receive either EMDR or CT-PTSD, allowing researchers to compare the benefits of each treatment.

To be eligible for this trial, participants must be at least 18 years old and have a PTSD diagnosis based on specific criteria. However, individuals who have severe intellectual disabilities, acute psychiatric conditions needing priority treatment, or those who have previously received EMDR or CT-PTSD are not eligible. Participants can expect to receive structured therapy focused on their personal treatment goals, and the study will also look at how patient characteristics might influence treatment outcomes. Overall, this trial aims to provide valuable insights into the best ways to support individuals with PTSD.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • age ≥18 years
• • meeting criteria for PTSD based on the Clinician-Administered PTSD Scale for DSM-5 (CAPS-5) with a total score ≥23
• Exclusion Criteria:
• • insufficient mastery of the Norwegian language
• • severe intellectual impairment (estimated IQ of 70 or less)
• • comorbid psychiatric illnesses in an acute phase where other types of treatment need to be prioritized (e.g. hospitalization)
• • history of EMDR or CT-PTSD treatment